PDVAC Executive summary 2017: 4th annual meeting

Salle B, WHO Headquarters, Geneva, Switzerland, 21-23 June 2017

30 June 2017
 | Meeting report
Download (332.2 kB)

Overview

On 21-23rd June 2017, WHO’s Product Development for Vaccines Advisory Committee (PDVAC) was convened for its 4th annual meeting. Product development progress in 10 pathogen areas that had been previously prioritized was discussed, and 4 new pathogens with candidates in, or approaching clinical development were reviewed. In addition, 6 key cross-cutting topics that have implications across several priority pathogens were considered. 

 

WHO Team
Immunization, Vaccines and Biologicals (IVB)
Editors
Product Development for Vaccines Advisory Committee (PDVAC)
Number of pages
4